These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29369974)

  • 21. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie.
    Schoretsanitis G; Kane JM; Correll CU; Marder SR; Citrome L; Newcomer JW; Robinson DG; Goff DC; Kelly DL; Freudenreich O; Piacentino D; Paulzen M; Conca A; Zernig G; Haen E; Baumann P; Hiemke C; Gründer G; ; Pharmakopsychiatrie TTDMTFOTAFNU
    J Clin Psychiatry; 2020 May; 81(3):. PubMed ID: 32433836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measuring movements in adolescents with psychosis using the Microsoft Kinect sensor: a pilot study exploring a new tool for assessing aspects of antipsychotic-induced parkinsonism.
    Rudå D; Einarsson G; Matthiassen JB; Correll CU; Jensen KG; Klauber DG; Richard CJ; Andersen ASS; Krøigaard S; Møllegaard Jepsen JR; Fagerlund B; Winge K; Clemmesen LKH; Pagsberg AK; Paulsen RR; Fink-Jensen A
    Child Adolesc Ment Health; 2020 May; 25(2):79-94. PubMed ID: 32307841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response.
    Mauri MC; Volonteri LS; Colasanti A; Fiorentini A; De Gaspari IF; Bareggi SR
    Clin Pharmacokinet; 2007; 46(5):359-88. PubMed ID: 17465637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.
    Bioque M; Llerena A; Cabrera B; Mezquida G; Lobo A; González-Pinto A; Díaz-Caneja CM; Corripio I; Aguilar EJ; Bulbena A; Castro-Fornieles J; Vieta E; Lafuente A; Mas S; Parellada M; Saiz-Ruiz J; Cuesta MJ; Bernardo M;
    Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26506856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders.
    Gerlach M; Hünnerkopf R; Rothenhöfer S; Libal G; Burger R; Clement HW; Fegert JM; Wewetzer Ch; Mehler-Wex C
    Pharmacopsychiatry; 2007 Mar; 40(2):72-6. PubMed ID: 17447177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of polypharmacy with second generation antipsychotics in patients with severe and persistent mental illness.
    Megna JL; Kunwar AR; Mahlotra K; Sauro MD; Devitt PJ; Rashid A
    J Psychiatr Pract; 2007 Mar; 13(2):129-37. PubMed ID: 17414692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.
    O'Donnell CP; Allott KA; Murphy BP; Yuen HP; Proffitt TM; Papas A; Moral J; Pham T; O'Regan MK; Phassouliotis C; Simpson R; McGorry PD
    J Clin Psychiatry; 2016 Dec; 77(12):e1610-e1617. PubMed ID: 27835719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis.
    Vázquez-Bourgon J; Pérez-Iglesias R; Ortiz-García de la Foz V; Suárez Pinilla P; Díaz Martínez Á; Crespo-Facorro B
    Psychopharmacology (Berl); 2018 Jan; 235(1):245-255. PubMed ID: 29075885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?
    Ballesteros A; Sánchez-Torres AM; López-Ilundain JM; Cabrera B; Lobo A; González-Pinto AM; Díaz-Caneja C; Corripio I; Vieta E; de la Serna E; Bobes J; Usall J; Contreras F; Lorente-Omeñaca R; Mezquida G; Bernardo M; Cuesta MJ;
    Psychol Med; 2018 Oct; 48(13):2247-2256. PubMed ID: 29331153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early use of clozapine for poorly responding first-episode psychosis.
    Agid O; Remington G; Kapur S; Arenovich T; Zipursky RB
    J Clin Psychopharmacol; 2007 Aug; 27(4):369-73. PubMed ID: 17632221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of LAI in first episode psychosis: an observational study--clinical reports.
    Cervone A; D'Onghia A; Ferrara M; Massaro CR
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S348-52. PubMed ID: 26417794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between antipsychotics and body mass index when treating patients with tics.
    Kompoliti K; Stebbins GT; Goetz CG; Fan W
    J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):277-81. PubMed ID: 20807065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis.
    Carbon M; Hsieh CH; Kane JM; Correll CU
    J Clin Psychiatry; 2017 Mar; 78(3):e264-e278. PubMed ID: 28146614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing the influence of dopamine D₂ polymorphisms and plasma drug concentrations on the clinical response to risperidone.
    Yasui-Furukori N; Tsuchimine S; Saito M; Nakagami T; Sugawara N; Fujii A; Kaneko S
    J Clin Psychopharmacol; 2011 Oct; 31(5):633-7. PubMed ID: 21869689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effect of haloperidol, olanzapine, and risperidone on plasma prolactin levels in patients with first-episode psychosis.
    Pérez-Iglesias R; Mata I; Martínez-García O; Garcia-Unzueta MT; Amado JA; Valdizán EM; Vázquez-Barquero JL; Crespo-Facorro B
    J Clin Psychopharmacol; 2012 Dec; 32(6):804-8. PubMed ID: 23131886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index.
    Haring L; Koido K; Vasar V; Leping V; Zilmer K; Zilmer M; Vasar E
    Schizophr Res; 2015 Dec; 169(1-3):22-29. PubMed ID: 26364730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment response of neurological soft signs in drug-naïve patients with a first psychotic episode.
    Cuesta MJ; Campos MS; García-Jalón E; Sánchez-Torres AM; Peralta V
    Schizophr Res; 2012 Aug; 139(1-3):144-50. PubMed ID: 22682370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.